NASDAQ:NH - NantHealth Stock Price, Forecast & News

NantHealth trades on the NASDAQ under the ticker symbol "NH."

NantHealth Inc (NASDAQ:NH) announced its quarterly earnings results on Thursday, August, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.01. The company earned $22.05 million during the quarter, compared to the consensus estimate of $24.50 million. NantHealth had a negative net margin of 105.82% and a negative return on equity of 10,106.10%. View NantHealth's Earnings History.

NantHealth is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for NantHealth.

1 brokerages have issued 12-month price objectives for NantHealth's stock. Their forecasts range from $1.00 to $1.00. On average, they expect NantHealth's share price to reach $1.00 in the next twelve months. This suggests that the stock has a possible downside of 46.2%. View Analyst Price Targets for NantHealth.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.

Media stories about NH stock have trended neutral recently, InfoTrie reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. NantHealth earned a news impact score of 0.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for NantHealth.

NantHealth saw a drop in short interest in January. As of January 31st, there was short interest totalling 170,600 shares, a drop of 23.9% from the January 15th total of 224,300 shares. Based on an average trading volume of 236,700 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.5% of the shares of the stock are short sold. View NantHealth's Current Options Chain.

Some companies that are related to NantHealth include Trivago (TRVG), Carbonite (CARB), Cars.com (CARS), Tucows (TCX), ZIX (ZIXI), Liberty Tripadvisor Holdings Inc Series A (LTRPA), Sohu.com (SOHU), CooTek (Cayman) (CTK), Brightcove (BCOV), GTY Technology (GTYH), Ooma (OOMA), Fang (SFUN), Castlight Health (CSLT), FRONTEO (FTEO) and Park City Group (PCYG).

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include Nantkwest (NK), Trevena (TRVN), Progenics Pharmaceuticals (PGNX), SCYNEXIS (SCYX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO), MannKind (MNKD), Aclaris Therapeutics (ACRS), Akorn (AKRX) and Anavex Life Sciences (AVXL).

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

NantHealth's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.46%), Jacobs Levy Equity Management Inc. (0.08%), Miracle Mile Advisors LLC (0.05%), Paragon Wealth Strategies LLC (0.03%) and Bank of America Corp DE (0.03%). View Institutional Ownership Trends for NantHealth.

NH stock was sold by a variety of institutional investors in the last quarter, including Miracle Mile Advisors LLC. View Insider Buying and Selling for NantHealth.

NH stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jacobs Levy Equity Management Inc., Paragon Wealth Strategies LLC and Bank of America Corp DE. View Insider Buying and Selling for NantHealth.

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NH stock can currently be purchased for approximately $1.86.

NantHealth has a market capitalization of $205.75 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe.View Additional Information About NantHealth.

The official website for NantHealth is http://www.nanthealth.com/.

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]